PTNS Versus Sham Efficacy in Treatment of BPS
Completed · Not applicable · Has a placebo group
Conditions studied: Interstitial Cystitis Bladder Pain Syndromes
In brief
This is a prospective, single center, double-blind, randomized, controlled trial comparing the efficacy of percutaneous tibial nerve stimulation to sham in the treatment of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC) through 12 weeks of therapy.
Key facts
- Study ID
- NCT02747420
- Run by
- NYU Langone Health
- People needed
- 40
- Starts
- 2016-06-01
- Expected to finish
- 2020-03-01
- Last updated by the study team
- 2021-01-26
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women ≥18 years old with visual analog scale > 5
- Cessation of all analgesics or other medication for pain for at least 2 weeks prior to the PTNS intervention
- Discontinuation of any other electrical stimulation methods for 3 months prior to PTNS intervention.
- Capable of giving informed consent
- Ambulatory
- Capable and willing to follow all study-relation procedures
You may not qualify if…
- Patients pregnant or planning to become pregnant during the study duration
- Botox use in pelvic floor muscles within the last year
- Current urinary or vaginal infections
- Current use of Interstim device
- History of a cardiac pacemaker
- Diagnosis of neuropathy
Where it is running
- New York University School of Medicine — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.